Cited by 793Schizophrenia research and treatmentMental Health and PsychiatryMultiple Sclerosis Research Studies

The DOI matches its Crossref record; 255 of the 258 references it cites were found in a registry or an index.

White Matter Changes in Schizophrenia: Evidence for Myelin-Related Dysfunction

Davis, Kenneth L., Stewart, Daniel G., Friedman, Joseph I., Buchsbaum, Monte, Harvey, Philip D., Hof, Patrick R., Buxbaum, Joseph, Haroutunian, Vahram·2003·Archives of General Psychiatry

DOI 10.1001/archpsyc.60.5.443

Open this paper in CoChat — free account

Abstract

Numerous lines of inquiry implicate connectivity as a central abnormality in schizophrenia. Myelination and factors that affect myelination, such as the function of oligodendroglia, are critical processes that could profoundly affect neuronal connectivity, especially given the diffuse distribution of oligodendrocytes and the widespread distribution of brain regions that have been implicated in schizophrenia. Multiple lines of evidence now converge to implicate oligodendroglia and myelin in schizophrenia. Imaging and neurocytochemical evidence, similarities with demyelinating diseases, age-related changes in white matter, myelin-related gene abnormalities, and morphologic abnormalities in the oligodendroglia demonstrated in schizophrenic brains are all examined in light of the hypothesis that oligodendroglial dysfunction and even death, with subsequent abnormalities in myelin maintenance and repair, contribute to the schizophrenic syndrome.

Integrity signals

Registry

Crossref · 10.1001/archpsyc.60.5.443

Cites

255 of 255 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Brain development during childhood and adolescence: a longitudinal MRI study
Giedd, J. N., Blumenthal, J., Jeffries, N. O., Castellanos, F. X., Liu, H., Zijdenbos, A., Paus, T., Evans, A. C., & Rapoport, J. L. (1999) · Nature Neuroscience · doi:10.1038/13158 · Cited by 5,552
The Molecular Biology of Axon Guidance
Tessier‐Lavigne, M., & Goodman, C. S. (1996) · Science · doi:10.1126/science.274.5290.1123 · Cited by 3,311
Synaptic density in human frontal cortex —Developmental changes and effects of aging
Peter R., H. (1979) · Brain Research · doi:10.1016/0006-8993(79)90349-4 · Cited by 2,645
Excitotoxic cell death
Choi, D. W. (1992) · Journal of Neurobiology · doi:10.1002/neu.480230915 · Cited by 2,329
Cognitive dysfunction in multiple sclerosis.
Rao, S. M., Leo, G. J., Bernardin, L., & Unverzagt, F. W. (1991) · Neurology · doi:10.1212/wnl.41.5.685 · Cited by 2,136
Regional Development of the Brain in Early Life
(1968) · Archives of Disease in Childhood · doi:10.1136/adc.43.229.388 · Cited by 2,107
Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685
Meta-analysis of regional brain volumes in schizophrenia
Wright, I. C., Rabe-Hesketh, S., Woodruff, P. W. R., David, A. S., Murray, R. M., & Bullmore, E. T. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.16 · Cited by 1,662
Glutamate neurotoxicity in cortical cell culture
Choi, D. W., Maulucci-Gedde, M., & Kriegstein, A. (1987) · Journal of Neuroscience · doi:10.1523/jneurosci.07-02-00357.1987 · Cited by 1,506

Flagged first, then by citations

Show all 258 references

3 of the 258 references couldn’t be matched to a known paper.

Sorted by citations

Items 201–300 of 793

Abnormalities in white matter connections between orbitofrontal cortex and anterior cingulate cortex and their associations with negative symptoms in schizophrenia: A DTI study
Ohtani, T., Sylvain Bouix, A., Hosokawa, T., Saito, Y., Eckbo, R., Ballinger, T., Rausch, A. C., Melonakos, E. D., & Kubicki, M. R. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.05.016 · Cited by 92
The myelin-pathogenesis puzzle in schizophrenia: a literature review
Karoutzou, G., Emrich, H. M., & Dietrich, D. E. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002096 · Cited by 95
The Human Homolog of the QKI Gene Affected in the Severe Dysmyelination “Quaking” Mouse Phenotype: Downregulated in Multiple Brain Regions in Schizophrenia
Haroutunian, V. H., Katsel, P., Dracheva, S. M., & Davis, K. L. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.10.1834 · Cited by 92
Self-citation
Hypothesis review: are clathrin-mediated endocytosis and clathrin-dependent membrane and protein trafficking core pathophysiological processes in schizophrenia and bipolar disorder?
Schubert, K. O., Föcking, M., Prehn, J. H. M., & Cotter, D. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.123 · Cited by 91
Right lateralized white matter abnormalities in first-episode, drug-naive paranoid schizophrenia
Guo, W., Liu, F., Liu, Z., Gao, K., Xiao, C., Chen, H., & Zhao, J. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.09.033 · Cited by 91
White matter and cognitive function in schizophrenia
Dwork, A. J., Mancevski, B., & Rosoklija, G. B. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007638 · Cited by 92
White Matter Abnormalities and Cognitive Impairment in Early-Onset Schizophrenia-Spectrum Disorders
Epstein, K. A., Cullen, K. R., Mueller, B. A., Robinson, P., Lee, S. S., & Kumra, S. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.12.007 · Cited by 90
Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: Marked differences between various antipsychotic drugs
Fernø, J., Skrede, S., Vik‐Mo, A. O., Håvik, B., & Steen, V. M. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-69 · Cited by 91
Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: possible mechanisms
Hsu, M., Huang, Y. S., & Ouyang, W. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01337-0 · Cited by 88
Making sense of neuroimaging in psychiatry
Malhi, G. S., & Lagopoulos, J. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01111.x · Cited by 90
Morphology of the corpus callosum at different stages of schizophrenia: Cross-sectional study in first-episode and chronic illness
Walterfang, M., WOOD, A. G., Reutens, D. C., Wood, S. J., Chen, J., Velakoulis, D., McGorry, P. D., & Pantelis, C. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.041251 · Cited by 87
Increased and Decreased Superficial White Matter Structural Connectivity in Schizophrenia and Bipolar Disorder
Ji, E., Guevara, P., Guevara, M., Grigis, A., Labra, N., Sarrazin, S., Hamdani, N., Bellivier, F., Delavest, M., Leboyer, M., et al. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz015 · Cited by 84
Evaluation of diffusion kurtosis imaging in ex vivo hypomyelinated mouse brains
Kelm, N. D., West, K. L., Carson, R. P., Gochberg, D. F., Ess, K. C., & Does, M. D. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.09.028 · Cited by 84
Linking white and grey matter in schizophrenia: Oligodendrocyte and neuron pathology in the prefrontal cortex
Höistad, M. (2009) · Frontiers in Neuroanatomy · doi:10.3389/neuro.05.009.2009 · Cited by 87
Gene Expression Profiling in Schizophrenia and Related Mental Disorders
Iwamoto, K., & Kato, T. (2006) · The Neuroscientist · doi:10.1177/1073858406287536 · Cited by 88
Diseases of White Matter and Schizophrenia-Like Psychosis
Walterfang, M., Wood, S. J., Velakoulis, D., Copolov, D., & Pantelis, C. (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2005.01678.x · Cited by 86
Increased MRI-based cortical grey/white-matter contrast in sensory and motor regions in schizophrenia and bipolar disorder
Jørgensen, K. N., Nerland, S., Norbom, L. B., Doan, N. T., Nesvåg, R., Mørch-Johnsen, L. E., Haukvik, U. K., Melle, I. S., Andreassen, O. A., Westlye, L. T., et al. (2016) · Psychological Medicine · doi:10.1017/s0033291716000593 · Cited by 86
Fronto-temporal disconnectivity and clinical short-term outcome in first episode psychosis: A DTI-tractography study
Luck, D., Buchy, L., Czechowska, Y., Bodnar, M. D., Pike, G. B., Campbell, J. S. W., Achim, A. M., MALLA, A. K., Joober, R., & Lepage, M. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.07.007 · Cited by 83
Oligodendrocyte Genes, White Matter Tract Integrity, and Cognition in Schizophrenia
Voineskos, A. N., Felsky, D., Kovacevic, N., Tiwari, A. K., Zai, C. C. H., Chakravarty, M. M., Lobaugh, N. J., Shenton, M. E., Rajji, T. K., Miranda, D., et al. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhs188 · Cited by 83
Tryptophan Metabolism and White Matter Integrity in Schizophrenia
Chiappelli, J., Postolache, T. T., Kochunov, P., Rowland, L. M., Wijtenburg, S. A., Shukla, D. K., Tagamets, M. A., Du, X. M., Savransky, A., Lowry, C. A., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.66 · Cited by 84
Behavioral and morphological alterations following neonatal excitotoxic lesions of the medial prefrontal cortex in rats
Schneider, M., & Koch, M. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.04.014 · Cited by 86
Prevention and Schizophrenia--The Role of Dietary Factors
McGrath, J. J., Brown, A., & Clair, D. S. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq121 · Cited by 83
Ultrastructural alterations of oligodendrocytes in prefrontal white matter in schizophrenia: a post-mortem morphometric study
Vikhreva, O. V., Rakhmanova, V. I., Orlovskaya, D. D., & Uranova, N. A. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.04.023 · Cited by 82
Neurodevelopment and inflammatory patterns in schizophrenia in relation to pathophysiology
Altamura, A. C., Pozzoli, S. M., Fiorentini, A., & Dell’Osso, B. M. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.08.015 · Cited by 80
Oligodendrocyte pathophysiology: a new view of schizophrenia
Segal, D., Koschnick, J. R., Slegers, L. H. A., & Hof, P. R. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570600722x · Cited by 82
Self-citation
Proteome and transcriptome analysis suggests oligodendrocyte dysfunction in schizophrenia
Martins-de-Souza, D. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.07.007 · Cited by 81
White matter fractional anisotropy and outcome in schizophrenia
Mitelman, S. A., Newmark, R. E., Torosjan, Y., Chu, K.-W., Brickman, A. M., Haznedar, M. M., Hazlett, E. A., Tang, C. Y., Shihabuddin, L., & Buchsbaum, M. S. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.06.016 · Cited by 81
Self-citation
White Matter and Behavioral Neurology
Filley, C. M. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1340.028 · Cited by 88
Diffusion tensor imaging of frontal lobe white matter tracts in schizophrenia
Buchsbaum, M. S., Schoenknecht, P., Torosjan, Y., Newmark, R. E., Chu, K.-W., Mitelman, S. A., Brickman, A. M., Shihabuddin, L., Haznedar, M. M., Hazlett, E. A., et al. (2006) · Annals of General Psychiatry · doi:10.1186/1744-859x-5-19 · Cited by 81
Self-citation
Multimodal Discrimination of Schizophrenia Using Hybrid Weighted Feature Concatenation of Brain Functional Connectivity and Anatomical Features with an Extreme Learning Machine
Qureshi, M. N. I., Oh, J., Cho, D., Jo, H. J., & Lee, B. (2017) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2017.00059 · Cited by 83
Calcium dyshomeostasis in white matter pathology
Matute, C. (2009) · Cell Calcium · doi:10.1016/j.ceca.2009.12.004 · Cited by 81
Mice with Altered Myelin Proteolipid Protein Gene Expression Display Cognitive Deficits Accompanied by Abnormal Neuron-Glia Interactions and Decreased Conduction Velocities
Tanaka, H., Ma, J., Tanaka, K. F., Takao, K., Komada, M., Tanda, K., Suzuki, A., Ishibashi, T., Baba, H., Isa, T., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3216-08.2009 · Cited by 79
Bioactive lipids in schizophrenia
Berger, G. E., Smesny, S., & Amminger, G. P. (2006) · International Review of Psychiatry · doi:10.1080/09540260600583072 · Cited by 80
White Matter Abnormalities in Schizophrenia and Schizotypal Personality Disorder
Lener, M. S., Wong, E., Tang, C. Y., Byne, W. M., Goldstein, K. E., Blair, N. J., Haznedar, M. M., New, A. S., Chemerinski, E., Chu, K.-W., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu093 · Cited by 79
Reduced white matter fractional anisotropy and clinical symptoms in schizophrenia: A voxel-based diffusion tensor imaging study
Nakamura, K., Kawasaki, Y., Takahashi, T., Furuichi, A., Noguchi, K., Seto, H., & Suzuki, M. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.09.006 · Cited by 81
INVESTIGATING THE NEURODEVELOPMENTAL HYPOTHESIS OF SCHIZOPHRENIA
Rehn, A., & Rees, S. M. (2005) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2005.04257.x · Cited by 76
Characterization of QKI Gene Expression, Genetics, and Epigenetics in Suicide Victims with Major Depressive Disorder
Klempan, T. A., Ernst, C., Deleva, V., Labonté, B., & Turecki, G. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.05.010 · Cited by 78
Cannabidiol induces intracellular calcium elevation and cytotoxicity in oligodendrocytes
Mato, S., Sánchez‐Gómez, M. V., & Matute, C. (2010) · Glia · doi:10.1002/glia.21044 · Cited by 79
Brain vascular heterogeneity: implications for disease pathogenesis and design of in vitro blood–brain barrier models
Noumbissi, M. E., Galasso, B., & Stins, M. F. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0097-2 · Cited by 79
Accelerated evolution of oligodendrocytes in the human brain
Berto, S., Mendizabal, I., Usui, N., Toriumi, K., Chatterjee, P., Douglas, C., Tamminga, C. A., Preuss, T. M., Yi, S. V., & Konopka, G. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1907982116 · Cited by 78
Calcium and glial cell death
Alberdi, E. M., Sánchez‐Gómez, M. V., & Matute, C. (2005) · Cell Calcium · doi:10.1016/j.ceca.2005.06.020 · Cited by 77
Novel Approaches to the Study of Postmortem Brain in Psychiatric Illness: Old Limitations and New Challenges
McCullumsmith, R. E., & Meador‐Woodruff, J. H. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.035 · Cited by 77
Nogo Receptor 1 (RTN4R) as a Candidate Gene for Schizophrenia: Analysis Using Human and Mouse Genetic Approaches
Hsu, R., Woodroffe, A., Lai, W., Cook, M. N., Mukai, J., Dunning, J. P., Swanson, D. J., Roos, J. L., Abecasis, G. R., Karayiorgou, M., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001234 · Cited by 76
Effect of age at onset of schizophrenia on white matter abnormalities
Kyriakopoulos, M., Pérez‐Iglesias, R., Woolley, J. B., Kanaan, R., Vyas, N. S., Barker, G. J., Frangou, S., & McGuire, P. K. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.108.055376 · Cited by 76
Volumetric analysis of sulci/gyri-defined in vivo frontal lobe regions in schizophrenia: Precentral gyrus, cingulate gyrus, and prefrontal region
Zhou, S.-Y., Suzuki, M., Hagino, H., Takahashi, T., Kawasaki, Y., Matsui, M., Seto, H., & Kurachi, M. (2005) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2005.05.005 · Cited by 75
Schizophrenia: From the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers
Stoeber, G., Ben‐Shachar, D., Cardon, M., Falkai, P., Fonteh, A. N., Gawlik, M., Glenthoj, B. Y., Grünblatt, E., Jablensky, A. V., Kim, Y., et al. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970902898980 · Cited by 76
Voxel-based morphometry (VBM) studies in schizophrenia—can white matter changes be reliably detected with VBM?
Melonakos, E. D., Shenton, M. E., Yogesh Rathi, A., Terry, D. P., Sylvain Bouix, A., & Kubicki, M. R. (2011) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.01.009 · Cited by 74
A high proportion of polymorphisms in the promoters of brain expressed genes influences transcriptional activity
Buckland, P. R., Hoogendoorn, B., Guy, C., Coleman, S. L., Smith, S. K., Buxbaum, J. D., Haroutunian, V. H., & O’Donovan, M. C. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.023 · Cited by 74
Self-citation
Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples
Hellard, S. L., Mühleisen, T. W., Djurovic, S., Fernø, J., Ouriaghi, Z., Mattheisen, M., Vasilescu, C., Raeder, M. B., Hansen, T. F., Strohmaier, J., et al. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.110 · Cited by 71
Association Between Prepartum Maternal Iron Deficiency and Offspring Risk of Schizophrenia: Population-Based Cohort Study With Linkage of Danish National Registers
Sørensen, H. J., Nielsen, P. R., Pedersen, C. B., & Mortensen, P. B. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp167 · Cited by 74
Investigation of corpus callosum in schizophrenia with diffusion imaging
Brambilla, P., Cerini, R., Gasparini, A., Versace, A., Andreone, N., Vittorini, E., Barbui, C., Pelizza, L., Nosè, M., & Barlocco, L. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.04.012 · Cited by 74
Functional lateralization of the sensorimotor cortex in patients with schizophrenia: effects of treatment with olanzapine
Bertolino, A., Blasi, G., Caforio, G., Latorre, V., Candia, M. D., Rubino, V., Callicott, J. H., Mattay, V. S., Bellomo, A., Scarabino, T., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.04.009 · Cited by 74
Metabolic Profiling Identifies Phospholipids as Potential Serum Biomarkers for Schizophrenia
Wang, D., Cheng, S. L., Fei, Q., Gu, H., Raftery, D., Cao, B., Sun, X., Yan, J., Zhang, C., & Wang, J. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2018.12.008 · Cited by 73
Neuroglial Roots of Neurodegenerative Diseases?
Rodríguez, J., & Verkhratsky, A. (2011) · Molecular Neurobiology · doi:10.1007/s12035-010-8157-x · Cited by 77
Shared abnormality of white matter integrity in schizophrenia and bipolar disorder: A comparative voxel-based meta-analysis
Dong, D., Wang, Y., Chang, X., Jiang, Y., Klugah‐Brown, B., Luo, C., & Yao, D. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.01.005 · Cited by 72
A Novel Ultrasensitive In Situ Hybridization Approach to Detect Short Sequences and Splice Variants with Cellular Resolution
Erben, L., He, M., Laeremans, A., Park, E., & Buonanno, A. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0834-6 · Cited by 73
Joint source based morphometry identifies linked gray and white matter group differences
Xu, L., Pearlson, G. D., & Calhoun, V. D. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.09.051 · Cited by 73
Genome-Wide Transcriptional Profiling and Structural Magnetic Resonance Imaging in the Maternal Immune Activation Model of Neurodevelopmental Disorders
Richetto, J., Chesters, R., Cattaneo, A., Labouesse, M. A., Gutierrez, A. M. C., Wood, T., Luoni, A., Meyer, U., Vernon, A. C., & Riva, M. A. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw320 · Cited by 72
Structural magnetic resonance imaging markers of susceptibility and transition to schizophrenia: A review of familial and clinical high risk population studies
Bois, C., Whalley, H. C., McIntosh, A. M., & Lawrie, S. M. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114541015 · Cited by 72
Stereological studies of capillary length density in the frontal cortex of schizophrenics
Kreczmański, P., Schmidt‐Kastner, R., Heinsen, H., Steinbusch, H. W. M., Hof, P. R., & Schmitz, C. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1003-y · Cited by 71
Self-citation
White matter ‘potholes’ in early-onset schizophrenia: A new approach to evaluate white matter microstructure using diffusion tensor imaging
White, T. J. H., Schmidt, M., & Karatekin, C. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2009.04.014 · Cited by 71
Candidate CSPG4 mutations and induced pluripotent stem cell modeling implicate oligodendrocyte progenitor cell dysfunction in familial schizophrenia
de Vrij, F. M. S., Bouwkamp, C. G., Gunhanlar, N., Shpak, G., Lendemeijer, B., Baghdadi, M., Gopalakrishna, S., Ghazvini, M., Li, T. M. W. Y., Quadri, M., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-017-0004-2 · Cited by 71
Roles of white matter in central nervous system pathophysiologies
Matute, C., & Ransom, B. R. (2012) · ASN Neuro · doi:10.1042/an20110060 · Cited by 70
Emerging functions of myelin‐associated proteins during development, neuronal plasticity, and neurodegeneration
Llorens, F., Gil, V., & del Río, J. A. (2010) · The FASEB Journal · doi:10.1096/fj.10-162792 · Cited by 72
Combined White Matter Imaging Suggests Myelination Defects in Visual Processing Regions in Schizophrenia
Palaniyappan, L. K., Al‐Radaideh, A., Mougin, O. E., Gowland, P. A., & Liddle, P. F. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.80 · Cited by 69
ErbB4 Genotype Predicts Left Frontotemporal Structural Connectivity in Human Brain
Konrad, A., Vučurević, G., Musso, F., Stoeter, P., Dahmen, N., & Winterer, G. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.112 · Cited by 69
Roles of glial cells in schizophrenia: Possible targets for therapeutic approaches
Takahashi, N., & Sakurai, T. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.11.001 · Cited by 67
Complementary diffusion tensor imaging study of the corpus callosum in patients with first-episode and chronic schizophrenia
Kong, X., Ouyang, X., Tao, H., Liu, H., Li, L., Zhao, J., Xue, Z., Wang, F., Jiang, S., Shan, B., et al. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100041 · Cited by 66
White matter changes in first episode psychosis and their relation to the size of sample studied: A DTI study
Melicher, T., Horáček, J., Hlinka, J., Španiel, F., Tintěra, J., Ibrahim, I., Mikoláš, P., Novák, T., Mohr, P., & Höschl, C. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.029 · Cited by 68
Myelin copper and the cuprizone model of schizophrenia
Konradi, C. L. (2010) · Frontiers in Bioscience-Scholar · doi:10.2741/s129 · Cited by 68
Gray and white matter volumetric and diffusion tensor imaging (DTI) analyses in the early stage of first-episode schizophrenia
Moriya, J., Kakeda, S., Abe, O., Gotō, N., Yoshimura, R., Hori, H., Ohnari, N., Satô, T., Aoki, S., Ohtomo, K., et al. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.10.002 · Cited by 65
White matter synapses
Alix, J. J. P., & Domingues, A. M. D. J. (2011) · Neurology · doi:10.1212/wnl.0b013e3182088273 · Cited by 67
Purinergic signalling and brain development
Rodrigues, R. J., Marques, J. M., & Cunha, R. A. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.12.001 · Cited by 72
Mapping pathological changes in brain structure by combining T1- and T2-weighted MR imaging data
Ganzetti, M., Wenderoth, N., & Mantini, D. (2015) · Neuroradiology · doi:10.1007/s00234-015-1550-4 · Cited by 65
Exploring Predictors of Outcome in the Psychosis Prodrome: Implications for Early Identification and Intervention
Niendam, T. A., Jalbrzikowski, M., & Bearden, C. E. (2009) · Neuropsychology Review · doi:10.1007/s11065-009-9108-z · Cited by 64
Gene expression microarray studies in polygenic psychiatric disorders: Applications and data analysis
Konradi, C. L. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.05.004 · Cited by 65
White Matter in Schizophrenia Treatment Resistance
Kochunov, P. V., Huang, J., Chen, S., Li, Y., Tan, S., Fan, F., Feng, W., Wang, Y., Rowland, L. M., Savransky, A., et al. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.18101212 · Cited by 64
The Course of Functional Decline in Geriatric Patients With Schizophrenia: Cognitive-Functional and Clinical Symptoms as Determinants of Change
Harvey, P. D. (2003) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.11.6.610 · Cited by 64
Self-citation
Targeting synapses and myelin in the prevention of schizophrenia
Woo, T., & Crowell, A. L. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.07.022 · Cited by 62
Altered white matter microstructure is associated with social cognition and psychotic symptoms in 22q11.2 microdeletion syndrome
Jalbrzikowski, M., Villalón‐Reina, J. E., Karlsgodt, K. H., Şentürk, D., Chow, C. C., Thompson, P. M., & Bearden, C. E. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00393 · Cited by 65
Common developmental genome deprogramming in schizophrenia — Role of Integrative Nuclear FGFR1 Signaling (INFS)
Narla, S. T., Lee, Y. W., Benson, C. A., Sarder, P., Brennand, K., Stachowiak, E. K., & Stachowiak, M. K. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2016.12.012 · Cited by 61
Reduced fronto-temporal connectivity is associated with frontal gray matter density reduction and neuropsychological deficit in schizophrenia
Spoletini, I., Cherubini, A., Di Paola, M., Banfi, G., Rüsch, N., Martinotti, G., Bria, P., Rubino, I. A., Siracusano, A., Caltagirone, C., et al. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2008.11.011 · Cited by 62
Aripiprazole inhibits superoxide generation from phorbol-myristate-acetate (PMA)-stimulated microglia in vitro: Implication for antioxidative psychotropic actions via microglia
Kato, T. A., Monji, A., Yasukawa, K., Mizoguchi, Y., Horikawa, H., Seki, Y., Hashioka, S., Han, Y.-H., Kasai, M., Sonoda, N., et al. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.03.019 · Cited by 63
Stem cells for the treatment of myelin loss
Keirstead, H. S. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.09.008 · Cited by 63
Metabolic mapping using 2D 31P-MR spectroscopy reveals frontal and thalamic metabolic abnormalities in schizophrenia
Smesny, S., Rosburg, T., Nenadić, I., Fenk, K. P., Kunstmann, S., Rzanny, R., Volz, H., & Sauer, H. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.12.023 · Cited by 61
White matter organization and neurocognitive performance variability in schizophrenia
Roalf, D. R., Ruparel, K., Verma, R., Elliott, M. A., Gur, R. E., & Gur, R. C. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.10.014 · Cited by 60
Effect of high-potency cannabis on corpus callosum microstructure
Rigucci, S., Marques, T. R., Forti, M. D., Taylor, H., Dell’Acqua, F., Mondelli, V., Bonaccorso, S., Simmons, A., David, A. S., Girardi, P., et al. (2015) · Psychological Medicine · doi:10.1017/s0033291715002342 · Cited by 59
Use of neuroanatomical pattern regression to predict the structural brain dynamics of vulnerability and transition to psychosis
Koutsouleris, N., Christian Gaser, B., Ronald Bottlender, A., Davatzikos, C. A., Decker, P., Jäger, M., Schmitt, G., Reiser, M. F., Möller, H., & Meisenzahl, E. M. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.08.032 · Cited by 59
The expression of long noncoding RNA NEAT1 is reduced in schizophrenia and modulates oligodendrocytes transcription
Katsel, P., Roussos, P., Fam, P. S., Khan, S., Tan, W., Hirose, T., Nakagawa, S., Pletnikov, M. V., & Haroutunian, V. H. (2019) · Schizophrenia · doi:10.1038/s41537-019-0071-2 · Cited by 61
Self-citation
Membrane Phospholipids and Cytokine Interaction in Schizophrenia
Yao, J. K., & van Kammen, D. P. (2004) · International review of neurobiology · doi:10.1016/s0074-7742(04)59012-8 · Cited by 58
A decade from discovery to therapy: Lingo-1, the dark horse in neurological and psychiatric disorders
Andrews, J. L., & Fernandez, F. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.06.009 · Cited by 58
Source-Based Morphometry Analysis of Group Differences in Fractional Anisotropy in Schizophrenia
Caprihan, A., Abbott, C., Yamamoto, J., Pearlson, G. D., Perrone‐Bizzozero, N. I., Jing Sui （Beijing Normal University）， my correct affiliation is beijing normal university, N. Q. U. O. S. A. T., & Calhoun, V. D. (2011) · Brain Connectivity · doi:10.1089/brain.2011.0015 · Cited by 61
Use of T1‐weighted/T2‐weighted magnetic resonance ratio images to elucidate changes in the schizophrenic brain
Iwatani, J., Ishida, T., Donishi, T., Ukai, S., Shinosaki, K., Terada, M., & Kaneoke, Y. (2015) · Brain and Behavior · doi:10.1002/brb3.399 · Cited by 57
N-acetylcysteine add-on treatment leads to an improvement of fornix white matter integrity in early psychosis: a double-blind randomized placebo-controlled trial
Klauser, P., Xin, L., Fournier, M., Griffa, A., Cleusix, M., Jenni, R., Cuénod, M., Rolf Gruetter, A., Hagmann, P., Conus, P., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0266-8 · Cited by 61
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates
Vita, A., Minelli, A., Barlati, S., Deste, G., Giacopuzzi, E., Valsecchi, P., Turrina, C., & Gennarelli, M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00402 · Cited by 57
Downregulation of oligodendrocyte transcripts is associated with impaired prefrontal cortex function in rats
Gregg, J. R., Herring, N. R., Naydenov, A. V., Hanlin, R. P., & Konradi, C. L. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.05.023 · Cited by 57
Chronic haloperidol treatment results in a decrease in the expression of myelin/oligodendrocyte‐related genes in the mouse brain
Narayan, S., Kass, K. E., & Thomas, E. A. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21161 · Cited by 56
Cytokines in schizophrenia: Possible role of anti‐inflammatory medications in clinical and preclinical stages
Mansur, R. B., Zugman, A., Asevedo, E. D. M., da Cunha, G. R., Bressan, R. A., & Brietzke, E. M. (2012) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2012.02354.x · Cited by 55
Synchrony in schizophrenia: a window into circuit-level pathophysiology
Spellman, T., & Gordon, J. A. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.08.009 · Cited by 59
Cannabis use and callosal white matter structure and integrity in recent-onset schizophrenia
Dekker, N., Schmitz, N., Peters, B. D., van Amelsvoort, T., LINSZEN, D. H., & de Haan, L. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2009.06.003 · Cited by 54

Authors: Davis, K. L., Stewart, D. G., Friedman, J. I., Buchsbaum, M., Harvey, P. D., Hof, P. R., Buxbaum, J., & Haroutunian, V.
Affiliations: Icahn School of Medicine at Mount Sinai (US)
ORCID: Davis, Kenneth L.
Friedman, Joseph I.
Buchsbaum, Monte
Harvey, Philip D.
Hof, Patrick R.
Buxbaum, Joseph
Haroutunian, Vahram
Venue: Archives of General Psychiatry
Publisher: American Medical Association (AMA)
Published: 2003-05-01
Volume: 60
Issue: 5
Pages: 443
ISSN: 0003-990X (ISSN-L)
DOI: 10.1001/archpsyc.60.5.443
OpenAlex: W2049973822
Cited by: 793
References: 258
Citations by year: 2026: 9 · 2025: 12 · 2024: 20 · 2023: 11 · 2022: 17 · 2021: 14 · 2020: 25 · 2019: 35 · 2018: 28 · 2017: 27 · 2016: 36 · 2015: 41 · 2014: 34 · 2013: 32 · 2012: 50
FWCI: 24.15
Type: journal article
Language: en
Open access: closed
Locations: Archives of General Psychiatry (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Keywords: schizophrenia, white matter, myelination, oligodendrocytes, myelin, neuronal connectivity, demyelinating disease, oligodendrocyte dysfunction, age-related white matter changes, neuroimaging
MeSH terms: Age Factors, Brain, Demyelinating Diseases, Humans, Myelin Sheath, Nerve Fibers, Myelinated, Oligodendroglia, Schizophrenia, Anisotropy, Cell Death, Protein Array Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

White Matter Changes in Schizophrenia: Evidence for Myelin-Related Dysfunction

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks